{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:09:10Z","timestamp":1787062150779,"version":"build-2736575974"},"reference-count":26,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2021,6,15]],"date-time":"2021-06-15T00:00:00Z","timestamp":1623715200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009947","name":"Merck Sharp & Dohme Corp","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009947","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Human Vaccines &amp; Immunotherapeutics"],"published-print":{"date-parts":[[2022,1,31]]},"DOI":"10.1080\/21645515.2021.1933874","type":"journal-article","created":{"date-parts":[[2021,6,15]],"date-time":"2021-06-15T12:27:23Z","timestamp":1623760043000},"page":"1-7","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":7,"title":["Use of M-M-R II outside of the routinely recommended age range \u2013 a systematic literature review"],"prefix":"10.1080","volume":"18","author":[{"given":"Manjiri","family":"Pawaskar","sequence":"first","affiliation":[{"name":"Merck & Co., Inc","place":["Kenilworth, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6159-4787","authenticated-orcid":false,"given":"Elvira","family":"Schmidt","sequence":"additional","affiliation":[{"name":"Certara Germany GmbH (Formerly Analytica Laser)","place":["Loerrach, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8731-6926","authenticated-orcid":false,"given":"Gary S.","family":"Marshall","sequence":"additional","affiliation":[{"name":"Norton Children\u2019s and University of Louisville School of Medicine","place":["Louisville, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1111-0892","authenticated-orcid":false,"given":"Jaime","family":"Fergie","sequence":"additional","affiliation":[{"name":"Driscoll Children\u2019s Hospital","place":["Corpus Christi, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Richardson","sequence":"additional","affiliation":[{"name":"Merck & Co., Inc","place":["Kenilworth, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise Parks","family":"Saldutti","sequence":"additional","affiliation":[{"name":"Merck & Co., Inc","place":["Kenilworth, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Se","family":"Li","sequence":"additional","affiliation":[{"name":"Former Employee of Merck & Co., Inc","place":["Kenilworth, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8052-5429","authenticated-orcid":false,"given":"Monika","family":"Neumann","sequence":"additional","affiliation":[{"name":"Certara Germany GmbH (Formerly Analytica Laser)","place":["Loerrach, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1674-4007","authenticated-orcid":false,"given":"Linnea","family":"Koller","sequence":"additional","affiliation":[{"name":"Certara Germany GmbH (Formerly Analytica Laser)","place":["Loerrach, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Kuter","sequence":"additional","affiliation":[{"name":"Former Employee of Merck & Co., Inc","place":["Kenilworth, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2021,6,15]]},"reference":[{"key":"e_1_3_3_2_1","unstructured":"Centers for Disease Control and Prevention (CDC). Complications of measles. [Internet]; 2020 [accessed 2020 October 30]. https:\/\/www.cdc.gov\/measles\/symptoms\/complications.html."},{"key":"e_1_3_3_3_1","unstructured":"Centers for Disease Control and Prevention (CDC). Epidemiology and prevention of vaccine-preventable diseases. Appendix E: data and statistics. Impact of Vaccines in the 20th and 21st Centuries; 2020 [accessed 2020 Nov 17]. https:\/\/www.cdc.gov\/vaccines\/pubs\/pinkbook\/downloads\/appendices\/e\/impact.pdf."},{"key":"e_1_3_3_4_1","unstructured":"Centers for Disease Control and Prevention (CDC). Measles cases and outbreaks. [Internet]; 2020 [accessed 2020 October 30]. https:\/\/www.cdc.gov\/measles\/cases-outbreaks.html."},{"key":"e_1_3_3_5_1","unstructured":"Centers for Disease Control and Prevention (CDC). Rubella in the U.S. [Internet]; 2020 [accessed 2020 Nov 17]. https:\/\/www.cdc.gov\/rubella\/about\/in-the-us.html."},{"key":"e_1_3_3_6_1","unstructured":"Centers for Disease Control and Prevention (CDC). Mumps cases and outbreaks. [Internet]; 2020 [accessed 2020 Nov 17]. https:\/\/www.cdc.gov\/mumps\/outbreaks.html."},{"issue":"3","key":"e_1_3_3_7_1","first-page":"1","article-title":"Use of combination measles, mumps, rubella, and varicella vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"59","author":"Marin M","year":"2010","unstructured":"Marin M, Broder KR, Temte JL, Snider DE, Seward JF. Use of combination measles, mumps, rubella, and varicella vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2010 May 7;59(RR\u20133):1\u201312.","journal-title":"MMWR Recomm Rep"},{"key":"e_1_3_3_8_1","unstructured":"European Centre for Disease Prevention and Control (ECDC). ECDC vaccine scheduler: recommended vaccinations: measles Mumps Rubella [Internet]. [accessed 2020 Dec 14]. https:\/\/vaccine\u2013schedule.ecdc.europa.eu\/Scheduler\/ByDisease?SelectedDiseaseId=8&SelectedCountryIdByDisease=\u22121;https:\/\/vaccine\u2013schedule.ecdc.europa.eu\/Scheduler\/ByDisease?SelectedDiseaseId=9&SelectedCountryIdByDisease=\u22121;https:\/\/vaccine\u2013schedule.ecdc.europa.eu\/Scheduler\/ByDisease?SelectedDiseaseId=10&SelectedCountryIdByDisease=\u22121."},{"key":"e_1_3_3_9_1","unstructured":"Centers for Disease Control and Prevention (CDC). Measles mumps and rubella (MMR) vaccination: what everyone should know [Internet]. [accessed 2020 December 14]. https:\/\/www.cdc.gov\/vaccines\/vpd\/mmr\/public\/index.html."},{"issue":"17","key":"e_1_3_3_10_1","first-page":"205","article-title":"Measles vaccines: WHO position paper - April 2017","volume":"92","author":"World Health Organization (WHO)","year":"2017","unstructured":"World Health Organization (WHO). Measles vaccines: WHO position paper - April 2017. Wkly Epidemiol Rec [Internet]. 2017 Apr 28;92(17):205\u201327. http:\/\/apps.who.int\/iris\/bitstream\/10665\/255149\/1\/WER9217.pdf?ua=1.","journal-title":"Wkly Epidemiol Rec"},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1912514"},{"issue":"3","key":"e_1_3_3_12_1","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1001\/jama.2020.26586","article-title":"Drop in vaccination causes surge in global measles cases, deaths","volume":"325","author":"Kuehn BM.","year":"2021","unstructured":"Kuehn BM. Drop in vaccination causes surge in global measles cases, deaths. Jama. 2021 Jan 19;325(3):213.","journal-title":"Jama"},{"key":"e_1_3_3_13_1","doi-asserted-by":"crossref","unstructured":"Higgins JPTTJ Chandler J Cumpston M Li T Page MJ Welch VA editors. Cochrane handbook for systematic reviews of interventions version 6.1 (updated September 2020). [Internet]; 2020 www.training.cochrane.org\/handbook.","DOI":"10.1002\/9781119536604"},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.1086\/378691"},{"issue":"5","key":"e_1_3_3_15_1","first-page":"299","article-title":"Prevalence of antibodies against measles, mumps, and rubella before and after vaccination of school-age children with three different triple combined viral vaccines, Rio Grande do Sul, Brazil, 1996","volume":"20","author":"Dos Santos BA","year":"2006","unstructured":"Dos Santos BA, Stralioto SM, Siqueira MM, Ranieri TS, Bercini M, Schermann MT, Wagner MB, Silveira TR. Prevalence of antibodies against measles, mumps, and rubella before and after vaccination of school-age children with three different triple combined viral vaccines, Rio Grande do Sul, Brazil, 1996. Revista Panamericana De Salud Publica\/Pan Am J Public Health. 2006Nov;20(5), 299\u2013306.","journal-title":"Revista Panamericana De Salud Publica\/Pan Am J Public Health"},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.04.027"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.08.055"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-200009000-00006"},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.1080\/00365540110026593"},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jadohealth.2004.02.021"},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2018.1489186"},{"issue":"4","key":"e_1_3_3_22_1","first-page":"240","article-title":"An evaluation of the adverse reaction potential of three measles-mumps-rubella combination vaccines","volume":"12","author":"Dos Santos BA","year":"2002","unstructured":"Dos Santos BA, Ranieri TS, Bercini M, Schermann MT, Famer S, Mohrdieck R, Maraskin T, Wagner MB. An evaluation of the adverse reaction potential of three measles-mumps-rubella combination vaccines. Revista Panamericana De Salud Publica\/Pan Am J Public Health. 2002 Oct 01;12(4):240\u201346.","journal-title":"Revista Panamericana De Salud Publica\/Pan Am J Public Health"},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6701a7"},{"key":"e_1_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d5928"},{"key":"e_1_3_3_25_1","unstructured":"Grey Literature International Steering Committee (GLISC). Guidelines for the production of scientific and technical reports: how to write and distribute grey literature Version 1.0. 2006; [accessed 2019 Sep 12]. http:\/\/eprints.rclis.org\/7469\/1\/nancy.pdf."},{"key":"e_1_3_3_26_1","first-page":"1","volume-title":"Introduction grey literature. 0.1 definitions. Grey literature in library and information studies","author":"Farace DJ","year":"2010","unstructured":"Farace DJ, Sch\u00f6pfel J. Introduction grey literature. 0.1 definitions. Grey literature in library and information studies. Berlin; New York: De Gruyter Saur; 2010. 1. https:\/\/library.oapen.org\/handle\/20.500.12657\/45661?show=full"},{"key":"e_1_3_3_27_1","unstructured":"Sch\u00f6pfel J. Towards a Prague definition of grey literature. at: twelfth international conference on grey literature: transparency in grey literature grey tech approaches to high tech issues; 2010 Dec 6-7; Prague (Czech Republic). 2019. https:\/\/archivesic.ccsd.cnrs.fr\/sic_00581570."}],"container-title":["Human Vaccines &amp; Immunotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/21645515.2021.1933874","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T15:07:09Z","timestamp":1744038429000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/21645515.2021.1933874"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,15]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1,31]]}},"alternative-id":["10.1080\/21645515.2021.1933874"],"URL":"https:\/\/doi.org\/10.1080\/21645515.2021.1933874","relation":{},"ISSN":["2164-5515","2164-554X"],"issn-type":[{"value":"2164-5515","type":"print"},{"value":"2164-554X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,15]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-04-09","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-05-12","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-05-18","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-06-15","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}